{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:05:32Z","timestamp":1788584732927,"version":"build-2803163510"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>To determine the relationship between PTX3 systemic and synovial levels and the clinical features of rheumatoid arthritis (RA) in a cohort of early, treatment na\u00efve patients and to explore the relevance of PTX3 expression in predicting response to conventional-synthetic (cs) Disease-Modifying-Anti-Rheumatic-Drugs (DMARDs) treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>PTX3 expression was analyzed in 119 baseline serum samples from early na\u00efve RA patients, 95 paired samples obtained 6-months following the initiation of cs-DMARDs treatment and 43 healthy donors. RNA-sequencing analysis and immunohistochemistry for PTX3 were performed on a subpopulation of 79 and 58 synovial samples, respectively, to assess PTX3 gene and protein expression. Immunofluorescence staining was performed to characterize PTX3 expressing cells within the synovium.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Circulating levels of PTX3 were significantly higher in early RA compared to healthy donors and correlated with disease activity at baseline and with the degree of structural damages at 12-months. Six-months after commencing cs-DMARDs, a high level of PTX3, proportional to the baseline value, was still detectable in the serum of patients, regardless of their response status. RNA-seq analysis confirmed that synovial transcript levels of PTX3 correlated with disease activity and the presence of mediators of inflammation, tissue remodeling and bone destruction at baseline. PTX3 expression in the synovium was strongly linked to the degree of immune cell infiltration, the presence of ectopic lymphoid structures and seropositivity for autoantibodies. Accordingly, PTX3 was found to be expressed by numerous synovial cell types such as plasma cells, fibroblasts, vascular and lymphatic endothelial cells, macrophages, and neutrophils. The percentage of PTX3-positive synovial cells, although significantly reduced at 6-months post-treatment as a result of global decreased cellularity, was similar in cs-DMARDs responders and non-responders.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study demonstrates that, early in the disease and prior to treatment modification, the level of circulating PTX3 is a reliable marker of RA activity and predicts a high degree of structural damages at 12-months. In the joint, PTX3 associates with immune cell infiltration and the presence of ectopic lymphoid structures. High synovial and peripheral blood levels of PTX3 are associated with chronic inflammation characteristic of RA. Additional studies to determine the mechanistic link are required.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2021.686795","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T05:43:11Z","timestamp":1624599791000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":21,"title":["Circulating and Synovial Pentraxin-3 (PTX3) Expression Levels Correlate With Rheumatoid Arthritis Severity and Tissue Infiltration Independently of Conventional Treatments Response"],"prefix":"10.3389","volume":"12","author":[{"given":"Marie-Astrid","family":"Boutet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Nerviani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Lliso-Ribera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Sironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Hands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Rivellese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Del Prete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katriona","family":"Goldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myles J.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Bottazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costantino","family":"Pitzalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid Arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","first-page":"334\u221244","DOI":"10.1097\/BOR.0b013e32835fd8eb","article-title":"New Learnings on the Pathophysiology of RA From Synovial Biopsies","volume":"25","author":"Pitzalis","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"761\u221272","DOI":"10.1136\/annrheumdis-2018-214539","article-title":"Synovial Cellular and Molecular Signatures Stratify Clinical Response to csDMARD Therapy and Predict Radiographic Progression in Early Rheumatoid Arthritis Patients","volume":"78","author":"Humby","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1016\/j.celrep.2019.07.091","article-title":"Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response Phenotypes","volume":"28","author":"Lewis","year":"2019","journal-title":"Cell Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"623\u221239","DOI":"10.1152\/physrev.00016.2017","article-title":"PTX3, a Humoral Pattern Recognition Molecule, in Innate Immunity, Tissue Repair, and Cancer","volume":"98","author":"Garlanda","year":"2018","journal-title":"Physiol Rev"},{"key":"B6","doi-asserted-by":"publisher","first-page":"328\u221234","DOI":"10.1038\/ni.1854","article-title":"Regulation of Leukocyte Recruitment by the Long Pentraxin PTX3","volume":"11","author":"Deban","year":"2010","journal-title":"Nat Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"647\u221261","DOI":"10.1038\/ki.2012.463","article-title":"Endogenous and Exogenous Pentraxin-3 Limits Postischemic Acute and Chronic Kidney Injury","volume":"83","author":"Lech","year":"2013","journal-title":"Kidney Int"},{"key":"B8","doi-asserted-by":"publisher","first-page":"905\u221225","DOI":"10.1084\/jem.20141268","article-title":"An Acidic Microenvironment Sets the Humoral Pattern Recognition Molecule PTX3 in a Tissue Repair Mode","volume":"212","author":"Doni","year":"2015","journal-title":"J Exp Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41590-020-00832-x","article-title":"Macrophage Expression and Prognostic Significance of the Long Pentraxin PTX3 in COVID-19","volume":"22","author":"Brunetta","year":"2021","journal-title":"Nat Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"73\u221283","DOI":"10.1111\/eci.12704","article-title":"Pentraxin 3 in Patients With Severe Sepsis or Shock: The ALBIOS Trial","volume":"47","author":"Caironi","year":"2017","journal-title":"Eur J Clin Invest"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2349\u221254","DOI":"10.1161\/01.CIR.0000145167.30987.2E","article-title":"Prognostic Significance of the Long Pentraxin PTX3 in Acute Myocardial Infarction","volume":"110","author":"Latini","year":"2004","journal-title":"Circulation"},{"key":"B12","doi-asserted-by":"publisher","first-page":"196\u2212202","DOI":"10.1046\/j.1365-2249.2000.01110.x","article-title":"Expression and Production of the Long Pentraxin PTX3 in Rheumatoid Arthritis (RA)","volume":"119","author":"Luchetti","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"171\u22125","DOI":"10.1016\/j.cyto.2016.04.009","article-title":"Levels of Serum Pentraxin 3, IL-6, Fetuin A and Insulin in Patients With Rheumatoid Arthritis","volume":"83","author":"Tekeo\u011flu","year":"2016","journal-title":"Cytokine"},{"key":"B14","doi-asserted-by":"publisher","first-page":"39\u221244","DOI":"10.5606\/ArchRheumatol.2018.6394","article-title":"The Relationship Between Serum Pentraxine 3 Levels and Hematological Markers in Patients With Rheumatoid Arthritis","volume":"33","author":"Sa\u011f","year":"2018","journal-title":"Arch Rheumatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"81\u20136","DOI":"10.5114\/aoms.2017.69726","article-title":"Is Pentraxin 3 Level an Effective Biomarker in Disease Activity in Patients With Rheumatoid Arthritis","volume":"16","author":"Balbaloglu","year":"2020","journal-title":"Arch Med Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"65\u221270","DOI":"10.1016\/j.cca.2018.01.035","article-title":"Acute Phase Reactant, Pentraxin 3, as a Novel Marker for the Diagnosis of Rheumatoid Arthritis","volume":"480","author":"Sharma","year":"2018","journal-title":"Clin Chim Acta Int J Clin Chem"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e55346","DOI":"10.1371\/journal.pone.0055346","article-title":"Blood Monocyte Chemotactic Protein-1 (MCP-1) and Adapted Disease Activity Score28-MCP-1: Favorable Indicators for Rheumatoid Arthritis Activity","volume":"8","author":"Liou","year":"2013","journal-title":"PloS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"681635","DOI":"10.1155\/2014\/681635","article-title":"Differential Associations of Inflammatory and Endothelial Biomarkers With Disease Activity in Rheumatoid Arthritis of Short Duration","volume":"2014","author":"Klimek","year":"2014","journal-title":"Mediators Inflamm"},{"key":"B19","doi-asserted-by":"publisher","first-page":"298\u2212301","DOI":"10.1016\/j.ijcard.2016.06.175","article-title":"Serum Pentraxin 3 Levels Are Negatively Associated With Carotid Intima Media Thickness in Non-Obese Rheumatoid Arthritis Patients","volume":"221","author":"Kahlow","year":"2016","journal-title":"Int J Cardiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1080\/14397595.2019.1681583","article-title":"Plasma Pentraxin 3 Is Associated With Progression of Radiographic Joint Damage, But Not Carotid Atherosclerosis, in Female Rheumatoid Arthritis Patients: 3-Year Prospective Study","volume":"30","author":"Asanuma","year":"2019","journal-title":"Mod Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"346\u221252","DOI":"10.1080\/03009742.2016.1244288","article-title":"Pentraxin 3 in Serum and Synovial Fluid of Patients With Rheumatoid Arthritis With and Without Autoantibodies","volume":"46","author":"Weitoft","year":"2017","journal-title":"Scand J Rheumatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1580\u22128","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid Arthritis Classification Criteria: An American College of Rheumatology\/European League Against Rheumatism Collaborative Initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"611\u22127","DOI":"10.1136\/annrheumdis-2013-204603","article-title":"Ultrasound-Guided Synovial Biopsy: A Safe, Well-Tolerated and Reliable Technique for Obtaining High-Quality Synovial Tissue From Both Large and Small Joints in Early Arthritis Patients","volume":"74","author":"Kelly","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2009.10.001","article-title":"The Disease Activity Score and the EULAR Response Criteria","volume":"23","author":"Fransen","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"D607\u221213","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: Protein\u2013Protein Association Networks With Increased Coverage, Supporting Functional Discovery in Genome-Wide Experimental Datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e31474","DOI":"10.1371\/journal.pone.0031474","article-title":"Pentraxin-3 as a Marker of Advanced Atherosclerosis Results From the Bruneck, ARMY and ARFY Studies","volume":"7","author":"Knoflach","year":"2012","journal-title":"PloS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"99\u2212106","DOI":"10.1016\/j.jneuroim.2013.04.009","article-title":"The Long Pentraxin PTX3 as a Correlate of Cancer-Related Inflammation and Prognosis of Malignancy in Gliomas","volume":"260","author":"Locatelli","year":"2013","journal-title":"J Neuroimmunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"Qupath: Open Source Software for Digital Pathology Image Analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"195\u2212204","DOI":"10.1038\/ni.2789","article-title":"Molecular Signatures of Antibody Responses Derived From a Systems Biology Study of Five Human Vaccines","volume":"15","author":"Li","year":"2014","journal-title":"Nat Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"928\u221242","DOI":"10.1038\/s41590-019-0378-1","article-title":"Defining Inflammatory Cell States in Rheumatoid Arthritis Joint Synovial Tissues by Integrating Single-Cell Transcriptomics and Mass Cytometry","volume":"20","author":"Zhang","year":"2019","journal-title":"Nat Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e0169830","DOI":"10.1371\/journal.pone.0169830","article-title":"Anti-Rheumatic Treatment Is Not Associated With Reduction of Pentraxin 3 in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis","volume":"12","author":"Deyab","year":"2017","journal-title":"PloS One"},{"key":"B32","doi-asserted-by":"publisher","first-page":"29983\u221292","DOI":"10.1074\/jbc.M805631200","article-title":"Cell-Specific Regulation of PTX3 by Glucocorticoid Hormones in Hematopoietic and Nonhematopoietic Cells","volume":"283","author":"Doni","year":"2008","journal-title":"J Biol Chem"},{"key":"B33","doi-asserted-by":"publisher","first-page":"28\u221235","DOI":"10.3109\/s10165-012-0630-0","article-title":"(SAA) Induces Pentraxin 3 (PTX3) Production in Rheumatoid Synoviocytes","volume":"23","author":"Satomura","year":"2013","journal-title":"Mod Rheumatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"102758","DOI":"10.1016\/j.autrev.2021.102758","article-title":"Novel Insights Into Macrophage Diversity in Rheumatoid Arthritis Synovium","volume":"20","author":"Boutet","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1618\u221231","DOI":"10.1093\/rheumatology\/keq045","article-title":"Neutrophil Function in Inflammation and Inflammatory Diseases","volume":"49","author":"Wright","year":"2010","journal-title":"Rheumatol Oxf Engl"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00407","article-title":"The \u201cSweet\u201d Side of a Long Pentraxin: How Glycosylation Affects PTX3 Functions in Innate Immunity and Inflammation","volume":"3","author":"Inforzato","year":"2013","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"11540\u221251","DOI":"10.1021\/bi0607453","article-title":"Structure and Function of the Long Pentraxin PTX3 Glycosidic Moiety: Fine-Tuning of the Interaction With C1q and Complement Activation","volume":"45","author":"Inforzato","year":"2006","journal-title":"Biochemistry"},{"key":"B38","doi-asserted-by":"publisher","first-page":"333\u221241","DOI":"10.1002\/JLB.3MR0218-062R","article-title":"Role of Chemokines in Ectopic Lymphoid Structures Formation in Autoimmunity and Cancer","volume":"104","author":"Nerviani","year":"2018","journal-title":"J Leukoc Biol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2167\u221285","DOI":"10.1084\/jem.20150282","article-title":"The Soluble Pattern Recognition Receptor PTX3 Links Humoral Innate and Adaptive Immune Responses by Helping Marginal Zone B Cells","volume":"213","author":"Chorny","year":"2016","journal-title":"J Exp Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e0120807","DOI":"10.1371\/journal.pone.0120807","article-title":"Recognition of Neisseria Meningitidis by the Long Pentraxin PTX3 and its Role as an Endogenous Adjuvant","volume":"10","author":"Bottazzi","year":"2015","journal-title":"PloS One"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218460","article-title":"Novel Autoantibodies Identified in ACPA-Negative Rheumatoid Arthritis","volume":"80","author":"Li","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00794","article-title":"The Long Pentraxin PTX3 as a Humoral Innate Immunity Functional Player and Biomarker of Infections and Sepsis","volume":"10","author":"Porte","year":"2019","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"102336","DOI":"10.1016\/j.jaut.2019.102336","article-title":"Complement C1q Synergizes With PTX3 in Promoting NLRP3 Inflammasome Over-Activation and Pyroptosis in Rheumatoid Arthritis","volume":"106","author":"Wu","year":"2020","journal-title":"J Autoimmun"},{"key":"B44","doi-asserted-by":"publisher","first-page":"R224","DOI":"10.1186\/ar3211","article-title":"Matrix Metalloproteinase-8 Deficiency Increases Joint Inflammation and Bone Erosion in the K\/BxN Serum-Transfer Arthritis Model","volume":"12","author":"Garc\u00eda","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02628","article-title":"The Long Pentraxin PTX3 in Bone Homeostasis and Pathology","volume":"10","author":"Parente","year":"2019","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"110628","DOI":"10.1016\/j.biopha.2020.110628","article-title":"Pentraxin 3 Inhibits Fibroblast Growth Factor 2 Induced Osteoclastogenesis in Rheumatoid Arthritis","volume":"131","author":"Zhao","year":"2020","journal-title":"BioMed Pharmacother"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00417","article-title":"The Long Pentraxin 3 Plays a Role in Bone Turnover and Repair","volume":"9","author":"Gr\u010devi\u0107","year":"2018","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s13018-021-02440-3","article-title":"The Long Pentraxin PTX3: A Novel Serum Marker to Improve the Prediction of Osteoporosis and Osteoarthritis Bone-Related Phenotypes","volume":"16","author":"Visconti","year":"2021","journal-title":"J Orthop Surg"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2841\u201350","DOI":"10.1002\/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6","article-title":"PTX3 in Small-Vessel Vasculitides: An Independent Indicator of Disease Activity Produced at Sites of Inflammation","volume":"44","author":"Fazzini","year":"2001","journal-title":"Arthritis Rheumatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01135","article-title":"PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases","volume":"10","author":"Ramirez","year":"2019","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"378\u221285","DOI":"10.1002\/acr.20094","article-title":"Increased Levels of Serum Pentraxin 3, a Novel Cardiovascular Biomarker, in Patients With Inflammatory Rheumatic Disease","volume":"62","author":"Hollan","year":"2010","journal-title":"Arthritis Care Res"},{"key":"B52","first-page":"87\u221299","article-title":"Serum Pentraxin 3 and Interleukin-6 Are Associated With Subclinical Atherosclerosis in Recent-Onset Rheumatoid Arthritis","volume":"17","author":"Mabrouk","year":"2010","journal-title":"Egypt J Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.686795\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T05:43:14Z","timestamp":1624599794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.686795\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,25]]},"references-count":52,"alternative-id":["10.3389\/fimmu.2021.686795"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.686795","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,25]]},"article-number":"686795"}}